Enovis falls on downbeat 2022 forecast
** Enovis Corp's shares ENOV.N slide 2.3% to $48.36
** Medical device maker expects FY adjusted profit in the
range of $2.20 per share to $2.25 per share, lower than
analysts' estimates of $2.26 - Refinitiv IBES data
** Co posted Q3 loss of $1.22 per share from continuing
operation, compared with a loss of $0.26 per share a year ago
urn:newsml:reuters.com:*:nGNE6JQKpj
** Including session losses, stock down ~39% YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on Enovis
See all newsU.S. RESEARCH ROUNDUP-Adobe, Dell Technologies, Zscaler
Enovis Corporation reports results for the quarter ended June 30 - Earnings Summary
Enovis slightly beats Q2 sales estimates, reaffirms 2026 guidance
Brief: Enovis Q2 Adjusted EPS USD 0.9 Vs. IBES Estimate USD 0.85
Enovis Q1 sales rise 5%, beat expectations